HK Stock Market Move | GD-HKGBA Holdings (01396) rose nearly 10% again, with a cumulative increase of over 40% this month. The company acquired Tian Dun Data to transform into the AI computing power track.
Yuexiawan Holdings (01396) has risen by nearly 10% again, with a cumulative increase of over 40% this month. As of the time of writing, it has risen by 6.91% to 6.81 Hong Kong dollars, with a trading volume of 30.1483 million Hong Kong dollars.
GD-HKGBA HLDGS (01396) has risen by nearly 10%, with a cumulative increase of over 40% within the month. As of the time of writing, it has risen by 6.91% to HK$6.81, with a trading volume of HK$30.1483 million.
Guoyuan's research report pointed out that GD-HKGBA HLDGS has completed a strategic transformation through the acquisition of Tiantun Data, forming a "Infrastructure + AI" dual-driven model. With the cluster capabilities of Tiantun Data, top client resources, and optimized financial structure after debt-to-equity conversion, the company has potential for revaluation. More importantly, after completing the transformation, the company has formed a high-quality combination of "low debt finance + high growth smart computing", possessing both the stability of traditional enterprise transformation and the growth potential of the technology sector. With the improvement of the company's business structure, growth expectations may gradually be realized in the performance of 2026.
According to public information, Shenzhen Tiantun Data Technology Co., Ltd. is one of China's top-tier smart computing construction and operation service providers, one of the earliest enterprises to layout national standard A-level third-party data centers, and is able to provide "green smart computing" full life cycle services. It operates more than 30,000 racks nationwide, with a total computing power scale exceeding 50,000P.
Related Articles

KEYNE LTD (00009): The Listing Review Committee has decided to uphold the delisting decision.

MNSO (09896) spent $243,500 to repurchase 51,200 shares on January 29th.
.png)
CMS(00867): The innovative drug phosphorus kitotinib cream has been approved for the Chinese market, becoming the first and only targeted therapy approved for the treatment of vitiligo in China.
KEYNE LTD (00009): The Listing Review Committee has decided to uphold the delisting decision.

MNSO (09896) spent $243,500 to repurchase 51,200 shares on January 29th.

CMS(00867): The innovative drug phosphorus kitotinib cream has been approved for the Chinese market, becoming the first and only targeted therapy approved for the treatment of vitiligo in China.
.png)
RECOMMEND

Late‑Night Broad Rally As Chip Sector Receives Major Boost: Price Hikes Announced
29/01/2026

Embodied Intelligence: From Frenzy To Breakthrough Through Real‑World Deployment
29/01/2026

Dollar Falls To Four‑Year Low, Trump “Adds Fuel To The Fire”: Not Worried, Dollar Performing Well, Will Find A Reasonable Level
29/01/2026


